Nerve Degeneration
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures.
|
8921280 |
1996 |
Status Epilepticus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine.
|
8635431 |
1996 |
Petit mal status
|
0.300 |
Biomarker
|
disease |
CTD_human |
Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine.
|
8635431 |
1996 |
Grand Mal Status Epilepticus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine.
|
8635431 |
1996 |
Complex Partial Status Epilepticus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine.
|
8635431 |
1996 |
Status Epilepticus, Subclinical
|
0.300 |
Biomarker
|
disease |
CTD_human |
Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine.
|
8635431 |
1996 |
Non-Convulsive Status Epilepticus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine.
|
8635431 |
1996 |
Simple Partial Status Epilepticus
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine.
|
8635431 |
1996 |
Nerve Degeneration
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Neurotrophin protection against toxicity induced by low potassium and nitroprusside in cultured cerebellar granule neurons.
|
8978711 |
1997 |
Diabetic Neuropathies
|
0.310 |
Therapeutic
|
group |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Symmetric Diabetic Proximal Motor Neuropathy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Asymmetric Diabetic Proximal Motor Neuropathy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Mononeuropathy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Polyneuropathies
|
0.300 |
Therapeutic
|
group |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Amyotrophy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Autonomic Neuropathy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Asymmetric Polyneuropathy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Neuralgia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Hyperalgesia
|
0.310 |
Therapeutic
|
phenotype |
CTD_human |
Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons.
|
15659614 |
2005 |
Mechanical Allodynia
|
0.310 |
Therapeutic
|
phenotype |
CTD_human |
Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons.
|
15659614 |
2005 |
Tonic-Clonic Epilepsy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Tonic-clonic seizures induce division of neuronal progenitor cells with concomitant changes in expression of neurotrophic factors in the brain of pilocarpine-treated mice.
|
16023256 |
2005 |
Allodynia
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons.
|
15659614 |
2005 |
Cryptogenic Tonic-Clonic Epilepsy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Tonic-clonic seizures induce division of neuronal progenitor cells with concomitant changes in expression of neurotrophic factors in the brain of pilocarpine-treated mice.
|
16023256 |
2005 |
Epilepsy, Tonic-Clonic, Familial
|
0.300 |
Biomarker
|
disease |
CTD_human |
Tonic-clonic seizures induce division of neuronal progenitor cells with concomitant changes in expression of neurotrophic factors in the brain of pilocarpine-treated mice.
|
16023256 |
2005 |
Epilepsy, Tonic-Clonic, Symptomatic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Tonic-clonic seizures induce division of neuronal progenitor cells with concomitant changes in expression of neurotrophic factors in the brain of pilocarpine-treated mice.
|
16023256 |
2005 |